Covered recipient · General Payments record
DANIEL TUCKER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2021–2024
$1,775.15
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.21 | 27 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $244.23 | 19 |
| Lundbeck LLC | $49.10 | 2 |
| Neurocrine BioSciences, Inc. | $46.02 | 3 |
| Otsuka America Pharmaceutical, Inc. | $29.03 | 1 |
| ITI, Inc. | $16.72 | 1 |
| Alkermes, Inc. | $16.11 | 1 |
| Janssen Pharmaceuticals, Inc | $13.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.86 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250767 | CMS |
| ABBVIE INC. | $14.28 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250769 | CMS |
| ABBVIE INC. | $5.61 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250771 | CMS |
| ABBVIE INC. | $23.61 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250773 | CMS |
| ABBVIE INC. | $23.61 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250775 | CMS |
| ABBVIE INC. | $6.97 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250777 | CMS |
| ABBVIE INC. | $21.63 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250779 | CMS |
| ABBVIE INC. | $10.80 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250781 | CMS |
| ABBVIE INC. | $8.21 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250783 | CMS |
| ABBVIE INC. | $5.16 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250785 | CMS |
| ABBVIE INC. | $20.33 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250787 | CMS |
| ABBVIE INC. | $6.66 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250789 | CMS |
| ABBVIE INC. | $27.11 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250791 | CMS |
| ABBVIE INC. | $9.01 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250793 | CMS |
| ABBVIE INC. | $17.59 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250795 | CMS |
| ABBVIE INC. | $8.45 | 11/04/2024 | Education | Undisputed | 01/23/2026 | 1106250797 | CMS |
| ABBVIE INC. | $8.31 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250799 | CMS |
| ABBVIE INC. | $5.26 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250801 | CMS |
| ABBVIE INC. | $5.77 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106250803 | CMS |
| Alkermes, Inc. | $16.11 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120611571 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.72 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143335412 | CMS |
| Janssen Pharmaceuticals, Inc | $13.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077987208 | CMS |
| Lundbeck LLC | $24.45 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145976705 | CMS |
| Lundbeck LLC | $24.65 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145976707 | CMS |
| Neurocrine Biosciences, Inc. | $16.00 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150872198 | CMS |
| Neurocrine Biosciences, Inc. | $14.49 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150876366 | CMS |
| Neurocrine Biosciences, Inc. | $15.53 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150873484 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.03 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118996281 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.